Primary Category:
Treatment Protocols
Disease Category:
Gynecologic, Ovarian
Status:
Closed
A Phase II Study of MK-3475 (Pembrolizumab) (NSC #776864) + Epacadostat (NSC #766086) in Recurrent Clear Cell Carcinoma of the Ovary
NCT#03602586
GY016 is permanently closed to accrual and will not advance to second stage accrual, effective February 1, 2021.